Oct 28, 2022
ERASE AF follow-up, recreational drugs and AF, etripamil, misuse of science, and diabetes as a cardiovascular risk factor are the topics John Mandrola, MD, discusses in this week’s podcast.
This podcast is intended for healthcare professionals only.
To read a partial transcript or to comment, visit:
https://www.medscape.com/twic
I. Follow-up on ERASE AF
II. Recreational Drugs
Four Commonly Abused Drugs Linked With Atrial Fibrillation
https://www.medscape.com/viewarticle/983052
III. Etripamil
RAPID: Positive Data for Etripamil Nasal Spray in Paroxysmal SVT
https://www.medscape.com/viewarticle/982787
- Milestone Pharmaceuticals Announces Positive Results from Phase 3 RAPID Clinical Trial of Etripamil Nasal Spray in Patients with Paroxysmal Supraventricular Tachycardia https://investors.milestonepharma.com/news-releases/news-release-details/milestone-pharmaceuticals-announces-positive-results-phase-3
IV. Misuse of Science
When Bad Actors Hijack Good Research
https://www.medscape.com/viewarticle/982936
- Level and Prevalence of Spin in Published Cardiovascular Randomized Clinical Trial Reports With Statistically Nonsignificant Primary Outcomes: A Systematic Review https://pubmed.ncbi.nlm.nih.gov/31050775/
V. Diabetes as a Risk Factor
Diabetes Becoming Less Potent Risk Factor for CVD Events
https://www.medscape.com/viewarticle/982801
- Trends in the Association Between Diabetes and Cardiovascular Events, 1994-2019 https://jamanetwork.com/journals/jama/fullarticle/2797494
You may also like:
Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine
https://www.medscape.com/features/public/machine
The Bob Harrington Show with Stanford University Chair of Medicine, Robert A. Harrington, MD.
https://www.medscape.com/author/bob-harrington
Questions or feedback, please contact
news@medscape.net